Bernhard Sielaff | Senior Scientist Ii

Bernhard Sielaff, Senior Scientist Ii, AbbVie

Dr. Bernhard Sielaff leads the Purification Group in Cell and Protein Sciences at the AbbVie Bioresearch Center (ABC) in Worcester, MA. His group is responsible for the design and purification of antigens in various formats to advance the Biologics Discovery pipeline in all therapeutic areas.


Festival of Biologics Day 1 @ 17:10

Strategies to Enable Antibody Discovery for Complex Targets

  • Stable recombinant proteins that resemble the native target structure and function are essential for the advancement of pipeline projects.
  • The complexity of many targets like membrane proteins poses a production challenge.
  • Different platforms for the generation of stable complex proteins and their use in antibody discovery will be presented.
last published: 31/Jan/23 09:55 GMT
last published: 31/Jan/23 09:55 GMT

back to speakers